Zhangjun Cheng
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 08, 2025
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances.Liangtao Zhao, Haolan Tang, Zhangjun Cheng
|Aug 15, 2023
Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis.Qiushi Yu, Zhengqing Lei, Weihu Ma
|Jun 23, 2023
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.Zhengqing Lei, Weihu Ma, Anfeng Si
|Mar 03, 2022
Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis.Tao Han, Hao Zheng, Jin Zhang
|Apr 19, 2019
Exosome-transmitted p120-catenin suppresses hepatocellular carcinoma progression via STAT3 pathways.Zhangjun Cheng, Zhengqing Lei, Pinghua Yang
Pageof 1
